Description |
nuclear receptor coactivator 2 |
estrogen receptor 2 |
Image |
|
|
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
- Diethylstilbestrol
- Estradiol
- Genistein
- Methyltrienolone
- 17-METHYL-17-ALPHA-DIHYDROEQUILENIN
- 4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol
- N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE
- 4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL
- 4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL
- 4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL
- (9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
- (9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL
- 3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL
- 3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL
- 2-chloro-5-nitro-N-phenylbenzamide
- dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate
- 4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol
- 4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL
- (2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID
- DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE
- 2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine
- 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID
- 4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL
- tributylstannanyl
- RALOXIFENE CORE
|
- Diethylstilbestrol
- Raloxifene
- Estrone
- Tamoxifen
- Estradiol
- Trilostane
- Estramustine
- Oxybenzone
- Genistein
- Prasterone
- Benzophenone
- Phthalic Acid
- Pyrazole
- Para-Mercury-Benzenesulfonic Acid
- Naringenin
- N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide
- 5-Alpha-Androstane-3-Beta,17beta-Diol
- 4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol
- Quercetin
- Afimoxifene
- Estriol
- Estrone sulfate
- MF101
- CHF 4227
- Lasofoxifene
- Bazedoxifene
- 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL
- 3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE
- [5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE
- 4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL
- 2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL
- 2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL
- (3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol
- 1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL
- 4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME
- 5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE
- 3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE
- 3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL
- (3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL
- (16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL
- (9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one
- Erteberel
- (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL
- Eugenol
- Octocrylene
- Enzacamene
- Equol
- 2-Methoxy-6-{(E)-[(4-methylphenyl)imino]methyl}phenol
|
Diseases |
|
|
GWAS |
- Cardiac Troponin-T levels ( 23247143)
- HDL cholesterol ( 30275531)
- HDL cholesterol levels ( 28334899)
- Intelligence (MTAG) ( 29326435)
- Metabolite levels ( 23823483)
- Metabolite levels (HVA-5-HIAA Factor score) ( 23319000)
- Multiple sclerosis ( 24076602)
- Non-small cell lung cancer ( 23144319)
- QT interval ( 24952745)
- Serum alkaline phosphatase levels ( 29403010)
- Spherical equivalent or myopia (age of diagnosis) ( 29808027)
- Subclinical trait of interstitial lung disease (basilar peel-core ratio of high attentuation areas on CT scan) ( 28521775)
|
- anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028)
- Atrial fibrillation ( 30061737)
- Chronotype ( 30696823)
- Cognitive ability, years of educational attainment or schizophrenia (pleiotropy) ( 31374203)
- Depression ( 29700475)
- Hematocrit ( 27863252)
- Hemoglobin concentration ( 27863252)
- Metabolite levels ( 23823483)
- Prostate cancer ( 26443449)
- Red blood cell count ( 27863252)
|
Interacting Genes |
63 interacting genes:
ACTN2
AHR
ANKRD11
AR
ARNT
BRCA1
CARM1
CCND3
CCNT1
CDK4
CREBBP
CTNNB1
DDX17
DDX5
DLX2
DLX5
EID1
EP300
ESR1
ESR2
ESRRB
ETV1
FOS
GMEB1
H3-4
H4-16
HIF1A
HNF4A
JUN
KIF5A
KIF5B
KIF5C
MAGEA11
MEF2C
NKX2-1
NR1I2
NR2F1
NR3C1
NR4A1
OPN1LW
PIAS3
PML
PPARA
PPARD
PPARG
PPFIA1
PPFIA4
PRMT1
PSMB9
RARA
RORA
RXRA
SLC30A9
SMARCE1
SRCAP
STAT6
SUMO1
TAF9
THRB
TP53
TXNRD2
VDR
YWHAH
|
98 interacting genes:
AGR3
AKAP13
AKT1
ARID5A
BCAS2
CALM1
CALM2
CALM3
CASC3
CASZ1
CCNC
CDK8
DAP3
DDX54
DKK3
DNMT3L
DNTTIP2
EP300
ESR1
IL13RA2
IL24
ITIH5
JMJD1C
KAT5
KLK9
LCK
LRATD2
MAD2L1
MAPK1
MAPK11
MED1
MED10
MED12
MED14
MED16
MED17
MED20
MED21
MED23
MED24
MED6
MED7
MEOX2
MKNK2
MMS19
MRC2
MSH2
NCOA1
NCOA2
NCOA3
NCOA6
NCOA7
NCOR1
NCOR2
NFKBIB
NOTCH2NLA
NR0B1
NR0B2
NRIP1
OXT
PELP1
PIAS1
PIAS2
PIAS3
PLSCR1
PNRC1
PNRC2
PPARGC1A
PPP5C
PRMT2
PRSS50
PSMC3IP
PSMC5
RBFOX2
RBM39
REXO4
RFX6
SERPINH1
SMAD2
SMAD3
SMAD4
SMARCE1
SP1
SRA1
SRC
SREBF1
STAT5A
TFF1
TRAM1
TRIM24
TRIM59
TRIP4
TXNRD1
WIPI1
YWHAH
YWHAQ
ZBTB17
ZNHIT3
|
Entrez ID |
10499 |
2100 |
HPRD ID |
09066 |
03390 |
Ensembl ID |
ENSG00000140396
|
ENSG00000140009
|
Uniprot IDs |
B4DPW8
Q15596
|
A0A348FV93
F1D8N3
Q0PTK2
Q7LCB3
Q92731
|
PDB IDs |
1GWQ
1GWR
1M2Z
1MV9
1MVC
1MZN
1P93
1T63
1T65
1UHL
1YOK
1ZDT
1ZDU
1ZKY
2AO6
2B1V
2B1Z
2B23
2FAI
2G44
2G5O
2LDC
2P15
2P1T
2P1U
2P1V
2Q7J
2Q7L
2YJD
2ZXZ
2ZY0
3A9E
3CLD
3DZU
3DZY
3E00
3E7C
3E94
3ERD
3FUG
3GN8
3K22
3K23
3KWY
3KYT
3L0E
3L0J
3L0L
3O1D
3O1E
3OAP
3OZJ
3PCU
3PLZ
3Q95
3R5M
3UP0
3UP3
4CSJ
4DOS
4E2J
4FHH
4FHI
4IA1
4IA2
4IA3
4IA7
4IQR
4IU7
4IUI
4IV2
4IV4
4IVW
4IVY
4IW6
4IW8
4IWC
4IWF
4K4J
4K6I
4M8E
4M8H
4NIE
4NQA
4OC7
4P6W
4P6X
4PLD
4PLE
4POH
4POJ
4PP3
4PP5
4PP6
4PPP
4PPS
4PXM
4Q0A
4Q13
4QE6
4QE8
4RFW
4RMC
4RMD
4RME
4RUO
4UDC
4UDD
4WG0
4ZN7
4ZN9
4ZNH
4ZNS
4ZNT
4ZNU
4ZNV
4ZNW
4ZO1
4ZSH
5APH
5APJ
5DI7
5DID
5DIE
5DIG
5DK9
5DKB
5DKE
5DKG
5DKS
5DL4
5DLR
5DMC
5DMF
5DP0
5DRJ
5DRM
5DTV
5DU5
5DUE
5DUG
5DUH
5DVS
5DVV
5DWE
5DWG
5DWI
5DWJ
5DX3
5DXB
5DXE
5DXG
5DXK
5DXM
5DXP
5DXQ
5DXR
5DY8
5DYB
5DYD
5DZ0
5DZ1
5DZ3
5DZH
5DZI
5E0W
5E0X
5E14
5E15
5E19
5E1C
5EC9
5EGV
5EHJ
5EI1
5EIT
5G3J
5G42
5G43
5G44
5G45
5G46
5G5W
5H1E
5HYR
5I4V
5IAW
5ICK
5KCC
5KCD
5KCE
5KCF
5KCT
5KCU
5KCW
5KD9
5KR9
5KRA
5KRC
5KRF
5KRH
5KRI
5KRJ
5KRK
5KRL
5KRM
5KRO
5L11
5LGA
5LYQ
5MK4
5NFP
5NFT
5NI5
5NI7
5NI8
5NIB
5Q17
5SYZ
5T1Z
5TLD
5TLF
5TLG
5TLL
5TLM
5TLO
5TLP
5TLT
5TLU
5TLV
5TLX
5TLY
5TM1
5TM2
5TM3
5TM4
5TM5
5TM6
5TM7
5TM8
5TM9
5TML
5TMM
5TMO
5TMQ
5TMR
5TMS
5TMT
5TMU
5TMV
5TMW
5TMZ
5TN1
5TN3
5TN4
5TN5
5TN6
5TN7
5TN8
5U2D
5UAN
5VB3
5VB5
5VB6
5VB7
5VQK
5VQL
5WGQ
5WZX
5XPL
5Y1J
5Y49
5YP5
5YXB
5YXD
5YXJ
5YXL
5Z12
6CZN
6D0F
6EL6
6EL7
6EL9
6ESN
6KNU
6KNV
6KNW
6OQX
6OQY
6OR1
6R7A
6R7J
6R7K
6SJM
|
1L2J
1NDE
1QKM
1U3Q
1U3R
1U3S
1U9E
1X76
1X78
1X7B
1X7J
1YY4
1YYE
1ZAF
2FSZ
2GIU
2I0G
2JJ3
2NV7
2QTU
2YJD
2YLY
2Z4B
3OLL
3OLS
3OMO
3OMP
3OMQ
4J24
4J26
4ZI1
5TOA
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|